MAZZON, EMANUELA
 Distribuzione geografica
Continente #
EU - Europa 136
NA - Nord America 62
AS - Asia 24
AF - Africa 20
Totale 242
Nazione #
US - Stati Uniti d'America 62
FR - Francia 47
IE - Irlanda 32
IT - Italia 21
CI - Costa d'Avorio 20
VN - Vietnam 14
IL - Israele 7
NL - Olanda 7
RU - Federazione Russa 7
UA - Ucraina 7
BE - Belgio 6
CZ - Repubblica Ceca 4
DE - Germania 2
ES - Italia 2
HK - Hong Kong 1
IN - India 1
IR - Iran 1
SE - Svezia 1
Totale 242
Città #
Dublin 32
Abidjan 20
Boardman 16
Catania 13
Dong Ket 13
Columbus 12
Jerusalem 7
Ashburn 6
Brussels 6
San Jose 6
Milan 4
Amsterdam 3
Mountain View 3
Groningen 2
Lake Forest 2
Aci Catena 1
Barcelona 1
Bremen 1
Chicago 1
Council Bluffs 1
Gatchina 1
Hanoi 1
Milpitas 1
Monopoli 1
Omsk 1
Paris 1
Perm 1
Pune 1
Sant Feliu de Llobregat 1
Seattle 1
St Petersburg 1
Sunnyvale 1
Voronezh 1
Totale 163
Nome #
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment, file dfe4d22b-7945-bb0a-e053-d805fe0a78d9 33
Characterization of the pathophysiological role of CD47 in uveal melanoma, file dfe4d229-e2cb-bb0a-e053-d805fe0a78d9 25
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences, file dfe4d22b-935f-bb0a-e053-d805fe0a78d9 25
Differential modulation and prognostic values of immune-escape genes in uveal melanoma, file dfe4d229-e6c3-bb0a-e053-d805fe0a78d9 18
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach., file dfe4d22b-b387-bb0a-e053-d805fe0a78d9 17
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets, file dfe4d229-e265-bb0a-e053-d805fe0a78d9 16
Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury: A case report., file dfe4d228-53d4-bb0a-e053-d805fe0a78d9 15
The H2S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide, file dfe4d22b-5bdb-bb0a-e053-d805fe0a78d9 15
Anticancer and differentiation properties of the nitric oxide derivative of lopinavir in human glioblastoma cells, file dfe4d22b-5bd2-bb0a-e053-d805fe0a78d9 14
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis, file dfe4d22b-7944-bb0a-e053-d805fe0a78d9 14
The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets, file dfe4d22b-64a9-bb0a-e053-d805fe0a78d9 13
Prediction of PD‐l1 expression in neuroblastoma via computational modeling, file dfe4d22b-88bb-bb0a-e053-d805fe0a78d9 13
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis, file dfe4d22b-5cfb-bb0a-e053-d805fe0a78d9 12
Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease, file bcd6e01c-2bd4-4680-9899-9d609b911b66 9
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF, file dfe4d229-c700-bb0a-e053-d805fe0a78d9 1
Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo, file dfe4d22b-7952-bb0a-e053-d805fe0a78d9 1
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets, file dfe4d22b-ba2e-bb0a-e053-d805fe0a78d9 1
Totale 242
Categoria #
all - tutte 1.029
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.029


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 1 0 0 1 0 1
2020/202119 1 1 2 0 0 0 0 0 2 0 0 13
2021/202215 2 1 3 4 0 0 2 0 0 2 1 0
2022/202381 1 3 1 3 1 17 1 6 18 1 29 0
2023/2024122 5 21 4 4 2 28 16 20 7 1 14 0
Totale 242